pharmaphorum

JANUARY 24, 2023

The future of R&D The Our Future Health project was funded from various bodies, but the pharma industry was willing to include £100 million of investment, in return for access and insights from the information gathered. Scientists are able to study the aggregated, de-identified genetics of these individuals.

Genetics 98

Genetics Drugs Genome Project Biobanking 98

Delveinsight

AUGUST 25, 2021

MAVYRET (Glecaprevir and pibrentasvir) (for Chronic HCV genotype), Skyrizi (Risankizumab) (for plaque psoriasis), and VENCLEXTA (Venetoclax) (for Chronic lymphocytic leukemia, and Acute Myeloid Leukemia) generated nearly same amount of revenue share i.e. 0.3% (USD 1.8 Imbruvica contributed USD 5.3 billion , around 11.5% of revenue share.

Vaccination 98

Vaccination Vaccine Drugs Sales 98

XTalks

NOVEMBER 9, 2023

While there are commonly used HPV tests in the market, not all are approved for primary screening and only provide limited information about the different genotypes of HPV present. Molecular testing for HPV types that are known to cause cervical cancer is certainly welcome as Pap tests are invasive and can be uncomfortable.

FDA Approval 64

FDA Approval HR Genotype Life Science 64